4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001415889-25-002941
INTERIM CEO gave up 3,559 shares (to pay taxes)
- INTERIM CEO acquired 9,467 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal INTERIM CEO | 2025-02-01 | Option exercise | +9,467 | 1,464,277 | D | ||
| Walker Neal INTERIM CEO | 2025-02-01 | Shares withheld for taxes | −3,559 | $2.48 | $8,826 | 1,460,718 | D |
| Derivatives | |||||||
| Walker Neal INTERIM CEO | 2025-02-01 | Option exercise · Restricted Stock Units | −9,467 | 28,400 | D | ||
| Walker Neal INTERIM CEO | 2025-02-03 | Grant or award · Restricted Stock Units | +253,900 | 253,900 | D | ||
| Walker Neal INTERIM CEO | 2025-02-03 | Grant or award · Employee Stock Option (Right to Buy) | +888,800 | 888,800 | D | ||
Loading xslF345X05/form4-02042025_040208.xml…